645 related articles for article (PubMed ID: 18822253)
1. [The French nationwide cystic fibrosis newborn screening program: strategy and results].
Munck A; Roussey M
Arch Pediatr; 2008 Jun; 15 Suppl 1():S1-6. PubMed ID: 18822253
[TBL] [Abstract][Full Text] [Related]
2. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.
Sontag MK; Hammond KB; Zielenski J; Wagener JS; Accurso FJ
J Pediatr; 2005 Sep; 147(3 Suppl):S83-8. PubMed ID: 16202790
[TBL] [Abstract][Full Text] [Related]
3. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
Rock MJ; Hoffman G; Laessig RH; Kopish GJ; Litsheim TJ; Farrell PM
J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
Parad RB; Comeau AM
J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789
[TBL] [Abstract][Full Text] [Related]
5. Combining immunoreactive trypsinogen and pancreatitis-associated protein assays, a method of newborn screening for cystic fibrosis that avoids DNA analysis.
Sarles J; Berthézène P; Le Louarn C; Somma C; Perini JM; Catheline M; Mirallié S; Luzet K; Roussey M; Farriaux JP; Berthelot J; Dagorn JC
J Pediatr; 2005 Sep; 147(3):302-5. PubMed ID: 16182665
[TBL] [Abstract][Full Text] [Related]
6. [Implementation of the neonatal cystic fibrosis screening program in Switzerland: beginning January 2011].
Mornand A; Barben J; Hafen G
Rev Med Suisse; 2011 Feb; 7(283):456, 458-60. PubMed ID: 21452515
[TBL] [Abstract][Full Text] [Related]
7. [Neonatal screening for cystic fibrosis].
Tellería Orriols JJ; Alonso Ramos MJ; Garrote Adrados JA; Fernández Carvajal I; Blanco Quirós A
An Esp Pediatr; 2002 Jul; 57(1):60-5. PubMed ID: 12139895
[TBL] [Abstract][Full Text] [Related]
8. [National program for neonatal screening for cystic fibrosis: implementation and preliminary results].
Navarro J; Grosskopf C; Vidailhet M; Briard ML; Farriaux JP
J Gynecol Obstet Biol Reprod (Paris); 2003 Feb; 32(1 Suppl):1S56-60. PubMed ID: 12592165
[TBL] [Abstract][Full Text] [Related]
9. The importance of sweat testing for older siblings of patients with cystic fibrosis identified by newborn screening.
Munck A; Houssin E; Roussey M
J Pediatr; 2009 Dec; 155(6):928-930.e1. PubMed ID: 19914431
[TBL] [Abstract][Full Text] [Related]
10. Implementation of the French nationwide cystic fibrosis newborn screening program.
Munck A; Dhondt JL; Sahler C; Roussey M
J Pediatr; 2008 Aug; 153(2):228-33, 233.e1. PubMed ID: 18534227
[TBL] [Abstract][Full Text] [Related]
11. A survey of newborn screening for cystic fibrosis in Europe.
Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
[TBL] [Abstract][Full Text] [Related]
12. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
[TBL] [Abstract][Full Text] [Related]
13. Implementation of informed consent for a cystic fibrosis newborn screening program in France: low refusal rates for optional testing.
Dhondt JL
J Pediatr; 2005 Sep; 147(3 Suppl):S106-8. PubMed ID: 16202772
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations.
Hammond KB; Abman SH; Sokol RJ; Accurso FJ
N Engl J Med; 1991 Sep; 325(11):769-74. PubMed ID: 1870650
[TBL] [Abstract][Full Text] [Related]
15. Positive neonatal screening for cystic fibrosis in neonates with renal failure.
Oosterveld MJ; Schilperoort JV; Lilien MR; Arets HG
Thorax; 2010 Jul; 65(7):652-3. PubMed ID: 20627926
[TBL] [Abstract][Full Text] [Related]
16. A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis.
Mayell SJ; Munck A; Craig JV; Sermet I; Brownlee KG; Schwarz MJ; Castellani C; Southern KW;
J Cyst Fibros; 2009 Jan; 8(1):71-8. PubMed ID: 18957277
[TBL] [Abstract][Full Text] [Related]
17. A new cystic fibrosis newborn screening algorithm: IRT/IRT1 upward arrow/DNA.
Sontag MK; Wright D; Beebe J; Accurso FJ; Sagel SD
J Pediatr; 2009 Nov; 155(5):618-22. PubMed ID: 19540513
[TBL] [Abstract][Full Text] [Related]
18. Thirty-years of screening for cystic fibrosis in East Anglia.
Calvin J; Hogg SL; McShane D; McAuley SA; Iles R; Ross-Russell R; MacLean FM; Heeley ME; Heeley AF;
Arch Dis Child; 2012 Dec; 97(12):1043-7. PubMed ID: 23076339
[TBL] [Abstract][Full Text] [Related]
19. High heterogeneity of CFTR mutations and unexpected low incidence of cystic fibrosis in the Mediterranean France.
des Georges M; Guittard C; Altiéri JP; Templin C; Sarles J; Sarda P; Claustres M
J Cyst Fibros; 2004 Dec; 3(4):265-72. PubMed ID: 15698946
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of cystic fibrosis after newborn screening: the Australasian experience--twenty years and five million babies later: a consensus statement from the Australasian Paediatric Respiratory Group.
Massie J; Clements B;
Pediatr Pulmonol; 2005 May; 39(5):440-6. PubMed ID: 15704202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
